BioElectronics Corp. has received over-the-counter use market clearance from the FDA for ActiPatch for the adjunctive treatment of musculoskeletal pain related to plantar fasciitis of the heel and osteoarthritis of the knee.

BioElectronics is an electroceutical company that develops wearable neuromodulation devices to safely mitigate neurologic diseases and improve quality of life. Its shortwave therapy technology uses low-power, pulsed electromagnetic fields to regulate electrical activity of the nervous system.

Read More